about
Chronic cerebrovascular dysfunction after traumatic brain injuryJuvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation.Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development.Aquaporin and brain diseasesSelective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivoNURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.High t-PA release by neonate brain microvascular endothelial cells under glutamate exposure affects neuronal fate.Up-regulation of Wnt/β-catenin expression is accompanied with vascular repair after traumatic brain injury.Memantine improves safety of thrombolysis for stroke.GluN2D subunit-containing NMDA receptors control tissue plasminogen activator-mediated spatial memory.Male and female mice exhibit divergent responses of the cortical vasculature to traumatic brain injury.Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders.Modulating the water channel AQP4 alters miRNA expression, astrocyte connectivity and water diffusion in the rodent brain.HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activatorA Novel Technique for Visualizing and Analyzing the Cerebral Vasculature in RodentsAcute intranasal osteopontin treatment in male rats following TBI increases the number of activated microglia but does not alter lesion characteristics
P50
Q33633462-3FF658E3-C9DA-43AE-91AE-1F9692441A40Q34727104-BDA15362-BE0B-4E69-951A-B7E35630FC0CQ37270632-2D9E0FFC-010C-47DD-8873-6F1D6C020DB6Q37523317-36713E89-99D5-437F-8FF4-3DDE58D03F76Q37649818-D5403EF5-351F-46AB-AA8A-D1681619C2A3Q38868099-43693344-8CC5-4845-B7F1-AF44285CBBD9Q38928837-87101A11-7800-4B37-9506-8105222A7B50Q42514937-74EAFB88-D183-4BED-88AC-E4A635686F3FQ46522929-64D92291-11CA-4419-8422-E2A080E15E56Q48414319-FED077D2-C49E-42CC-A036-ACE7EBFA27C1Q50785406-6F55AF5E-0D38-4783-85A4-FD54C92646FDQ52323649-4C640E7A-D93B-4BA0-B6CC-F2DB9C417980Q54300081-88C37ED0-D28F-4C86-912D-CCD30BD630DEQ54967591-2A7AAEE6-2455-4452-B01C-D47C61DCCB41Q60597641-752739A0-5120-4236-A534-1E72783A99A4Q88688108-E3C0A8CB-5268-4BFF-BFCC-175DCA9B2DAAQ92501283-0A90CE94-3EE3-4D4A-84E0-C0B68AA6C1E5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Amandine Jullienne
@ast
Amandine Jullienne
@en
Amandine Jullienne
@es
Amandine Jullienne
@nl
type
label
Amandine Jullienne
@ast
Amandine Jullienne
@en
Amandine Jullienne
@es
Amandine Jullienne
@nl
prefLabel
Amandine Jullienne
@ast
Amandine Jullienne
@en
Amandine Jullienne
@es
Amandine Jullienne
@nl
P106
P31
P496
0000-0001-9458-055X